Clinigen Group PLC (CLIN) Receives GBX 1,200.83 Average Target Price from Analysts

Shares of Clinigen Group PLC (LON:CLIN) have been given an average rating of “Buy” by the six research firms that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is GBX 1,200.83 ($16.16).

A number of equities analysts recently issued reports on CLIN shares. Peel Hunt reissued an “add” rating and issued a GBX 1,200 ($16.15) price objective on shares of Clinigen Group in a report on Thursday, September 28th. N+1 Singer restated a “buy” rating and set a GBX 1,225 ($16.49) target price on shares of Clinigen Group in a research note on Wednesday, November 29th. Berenberg Bank began coverage on shares of Clinigen Group in a research note on Wednesday, November 1st. They set a “hold” rating and a GBX 1,200 ($16.15) target price on the stock. Finally, Royal Bank Of Canada restated an “outperform” rating and set a GBX 1,360 ($18.30) target price on shares of Clinigen Group in a research note on Tuesday, November 7th.

Shares of Clinigen Group (CLIN) traded down GBX 46.50 ($0.63) during midday trading on Friday, hitting GBX 988.50 ($13.30). 565,790 shares of the stock were exchanged, compared to its average volume of 404,240. Clinigen Group has a 12-month low of GBX 700 ($9.42) and a 12-month high of GBX 1,187 ($15.98).

Clinigen Group (LON:CLIN) last posted its quarterly earnings data on Thursday, September 28th. The company reported GBX 41.80 ($0.56) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of GBX 41.20 ($0.55) by GBX 0.60 ($0.01). The company had revenue of £302.30 million for the quarter. Clinigen Group had a net margin of 0.70% and a return on equity of 0.98%.

The business also recently disclosed a dividend, which was paid on Friday, December 1st. Stockholders of record on Thursday, November 9th were given a dividend of GBX 3.40 ($0.05) per share. The ex-dividend date was Thursday, November 9th. This represents a dividend yield of 0.32%. This is a boost from Clinigen Group’s previous dividend of $1.60.

In related news, insider Shaun Edward Chilton sold 100,000 shares of the firm’s stock in a transaction on Friday, October 13th. The shares were sold at an average price of GBX 1,150 ($15.48), for a total value of £1,150,000 ($1,547,779.27). Also, insider John Bacon sold 250,000 shares of the firm’s stock in a transaction on Monday, October 2nd. The shares were sold at an average price of GBX 1,093 ($14.71), for a total transaction of £2,732,500 ($3,677,658.14). Over the last three months, insiders sold 354,955 shares of company stock valued at $393,289,235.

TRADEMARK VIOLATION WARNING: This story was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/05/clinigen-group-plc-clin-receives-gbx-1200-83-average-target-price-from-analysts.html.

Clinigen Group Company Profile

Analyst Recommendations for Clinigen Group (LON:CLIN)

Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply